Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / S&P BIOTECH
-
Number of holders
-
628
-
Total 13F shares, excl. options
-
62,933,735
-
Shares change
-
-3,489,882
-
Total reported value, excl. options
-
$7,912,765,727
-
Value change
-
-$446,273,061
-
Put/Call ratio
-
216%
-
Number of buys
-
266
-
Number of sells
-
-254
-
Price
-
$125.71
Significant Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q3 2021
785 filings reported holding XBI - SPDR SERIES TRUST - S&P BIOTECH as of Q3 2021.
SPDR SERIES TRUST - S&P BIOTECH (XBI) has 628 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62,933,735 shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (6,854,054 shares), BANK OF AMERICA CORP /DE/ (6,003,649 shares), BNP PARIBAS ARBITRAGE, SA (5,214,207 shares), TORONTO DOMINION BANK (5,069,535 shares), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (4,905,000 shares), MORGAN STANLEY (3,316,128 shares), CITIGROUP INC (2,643,333 shares), JPMORGAN CHASE & CO (2,640,450 shares), BARCLAYS PLC (1,874,123 shares), and UBS Group AG (1,469,803 shares).
This table shows the top 628 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.